{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=VISTA", "query": { "intervention": "VISTA" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 37, "total_pages": 4, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=VISTA&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-06T10:27:55.060Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01419314", "title": "Lower Extremity Splinting to Manage Pain and Sleep Disturbances Associated With HIV/AIDS Related Peripheral Neuropathy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "HIV", "AIDS", "Peripheral Neuropathy", "Pain", "Sleep" ], "interventions": [ { "name": "Splinting application to the lower extremities", "type": "DEVICE" }, { "name": "Splint liner application", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Texas Woman's University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 46, "start_date": "2011-08", "completion_date": "2012-06", "has_results": true, "last_update_posted_date": "2013-01-03", "last_synced_at": "2026-09-06T10:27:55.060Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01419314" }, { "nct_id": "NCT01694667", "title": "Omega-3 Fatty Acids for Hyperactivity Treatment in Autism Spectrum Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Autism Spectrum Disorders", "Hyperactivity" ], "interventions": [ { "name": "Omega-3 Fatty Acids", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Hugo W. Moser Research Institute at Kennedy Krieger, Inc.", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "5 Years", "maximum_age": "8 Years", "sex": "ALL", "summary": "5 Years to 8 Years" }, "enrollment_count": 57, "start_date": "2012-09", "completion_date": "2013-05", "has_results": true, "last_update_posted_date": "2020-08-31", "last_synced_at": "2026-09-06T10:27:55.060Z", "location_count": 1, "location_summary": "Multiple Locations, Maryland", "locations": [ { "city": "Multiple Locations", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01694667" }, { "nct_id": "NCT07450664", "title": "Observational Study of VYKAT™ XR in Patients With Prader-Willi Syndrome", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Prader-Willi Syndrome" ], "interventions": [ { "name": "VYKAT XR", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Soleno Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": null, "sex": "ALL", "summary": "4 Years and older" }, "enrollment_count": 200, "start_date": "2025-11-26", "completion_date": "2028-03-02", "has_results": false, "last_update_posted_date": "2026-08-21", "last_synced_at": "2026-09-06T10:27:55.060Z", "location_count": 24, "location_summary": "Phoenix, Arizona • Los Angeles, California • Sacramento, California + 21 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT07450664" }, { "nct_id": "NCT02812875", "title": "A Study of CA-170 (Oral PD-L1, PD-L2 and VISTA Checkpoint Antagonist) in Patients With Advanced Tumors and Lymphomas", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Advanced Solid Tumors or Lymphomas" ], "interventions": [ { "name": "CA-170", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Curis, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 71, "start_date": "2016-05", "completion_date": "2020-05-07", "has_results": false, "last_update_posted_date": "2020-06-26", "last_synced_at": "2026-09-06T10:27:55.060Z", "location_count": 11, "location_summary": "San Francisco, California • Denver, Colorado • Sarasota, Florida + 7 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Sarasota", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT02812875" }, { "nct_id": "NCT05708950", "title": "A Clinical Trial of KVA12123 [TBS-2025] Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Cancer", "Solid Tumor", "Melanoma", "Carcinoma", "Sarcoma", "Lung Cancer", "Prostate Cancer", "Breast Cancer", "Colo-rectal Cancer", "Uterine Cancer", "Pancreatic Cancer", "Gastric Cancer", "Esophageal Cancer", "Thyroid Cancer", "Ovarian Cancer", "Kidney Cancer", "Head and Neck Cancer" ], "interventions": [ { "name": "KVA12123 - Dose Escalation", "type": "DRUG" }, { "name": "KVA12123 Plus Pembrolizumab - Dose Escalation", "type": "DRUG" }, { "name": "KVA12123 - Dose Expansion", "type": "DRUG" }, { "name": "KVA12123 Plus Pembrolizumab - Dose Expansion", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Kineta Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 40, "start_date": "2023-03-03", "completion_date": "2025-12-18", "has_results": false, "last_update_posted_date": "2026-06-18", "last_synced_at": "2026-09-06T10:27:55.060Z", "location_count": 7, "location_summary": "Santa Monica, California • Denver, Colorado • Sarasota, Florida + 4 more", "locations": [ { "city": "Santa Monica", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Sarasota", "state": "Florida" }, { "city": "Ann Arbor", "state": "Michigan" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT05708950" }, { "nct_id": "NCT03124329", "title": "Efficacy of Methods to Treat Multiple Gingival Recession Defects", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Gingival Recession" ], "interventions": [ { "name": "Coronally Advanced Flap", "type": "PROCEDURE" }, { "name": "Intrasulcular Tunneling", "type": "PROCEDURE" }, { "name": "Vestibular Incision Subperiosteal Tunnel Access (VISTA)", "type": "BIOLOGICAL" }, { "name": "Leukocyte-Platelet Rich Fibrin (L-PRF)", "type": "DEVICE" } ], "intervention_types": [ "PROCEDURE", "BIOLOGICAL", "DEVICE" ], "sponsor": "University of Southern California", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 0, "start_date": "2017-05-01", "completion_date": "2019-06-19", "has_results": false, "last_update_posted_date": "2025-10-15", "last_synced_at": "2026-09-06T10:27:55.060Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03124329" }, { "nct_id": "NCT00829803", "title": "A Study to Assess Indices of SNAP vs VISTA on Surgical Patients Undergoing General Anesthesia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Anesthesia, General" ], "interventions": [ { "name": "SNAP monitor; Bispectral Index Monitor (BIS Monitor)", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Stryker Instruments", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 40, "start_date": "2009-02", "completion_date": "2011-01", "has_results": false, "last_update_posted_date": "2021-11-09", "last_synced_at": "2026-09-06T10:27:55.060Z", "location_count": 4, "location_summary": "Miami, Florida • Chicago, Illinois • Royal Oak, Michigan + 1 more", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Royal Oak", "state": "Michigan" }, { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00829803" }, { "nct_id": "NCT06485206", "title": "Evaluation of Safety and Effectiveness of Primary Hybrid Construct of Mobi-C and ACDF in the Treatment of Two-level Symptomatic Degenerative Disc Disease in the Cervical Spine.", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Degenerative Disc Disease" ], "interventions": [ { "name": "One level Mobi-C and one level fusion", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Highridge Medical", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "22 Years", "maximum_age": "69 Years", "sex": "ALL", "summary": "22 Years to 69 Years" }, "enrollment_count": 97, "start_date": "2024-09-01", "completion_date": "2029-05", "has_results": false, "last_update_posted_date": "2025-01-27", "last_synced_at": "2026-09-06T10:27:55.060Z", "location_count": 2, "location_summary": "Sacramento, California • Southfield, Michigan", "locations": [ { "city": "Sacramento", "state": "California" }, { "city": "Southfield", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT06485206" }, { "nct_id": "NCT07513597", "title": "Assessment of the Effects of a Daily Supplement 4Life Transfer Factor Vista Containing AREDS2 Formula on Skin Carotenoid Levels Using a Non-invasive Detection", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Skin Carotenoids" ], "interventions": [ { "name": "Dietary Supplement", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "4Life Research, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 24, "start_date": "2025-10-16", "completion_date": "2026-02-14", "has_results": false, "last_update_posted_date": "2026-04-07", "last_synced_at": "2026-09-06T10:27:55.060Z", "location_count": 1, "location_summary": "Sandy City, Utah", "locations": [ { "city": "Sandy City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT07513597" }, { "nct_id": "NCT05894655", "title": "Community-engaged Optimization of COVID-19 Rapid Evaluation And TEsting Experiences", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "COVID-19", "COVID-19 Pandemic" ], "interventions": [ { "name": "COVID-19 walk-up, on-site testing strategy", "type": "BEHAVIORAL" }, { "name": "Community Health Worker (CHW) leading testing navigation and general preventive care reminders", "type": "BEHAVIORAL" }, { "name": "No-cost self-testing kit vending machines", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of California, San Diego", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 6527, "start_date": "2023-08-28", "completion_date": "2025-10-08", "has_results": false, "last_update_posted_date": "2025-11-04", "last_synced_at": "2026-09-06T10:27:55.060Z", "location_count": 1, "location_summary": "San Ysidro, California", "locations": [ { "city": "San Ysidro", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05894655" } ] }